期刊文献+

全容积表观扩散系数直方图鉴别乳头状与嫌色细胞肾癌的价值

Value of Apparent Diffusion Coefficient Histogram in Differentiating Papillary and Chromophobic Renal Carcinoma
在线阅读 下载PDF
导出
摘要 目的探讨表观扩散系数(Apparent Diffusion Coefficient,ADC)直方图鉴别乳头状肾癌(Papillary Renal Cell Carcinoma,p RCC)与嫌色细胞肾癌(Chromophobe Renal Cell Carcinoma,Ch RCC)的价值。方法回顾性分析23例p RCC与20例Ch RCC的影像学资料。患者均行肾脏常规MRI平扫、增强扫描以及扩散加权成像(Diffusion-Weighted Imaging,DWI)检查。测量两组患者ADC直方图各参数值(包括:最小值、平均值、中位值、最大值、偏度值以及峰度值)。统计分析各参数差异及其诊断效能。结果 pRCC的ADC直方图最小值、平均值以及中位值均低于Ch RCC,而最大值高于Ch RCC(P<0.05)。p RCC以正偏态分布为主,而Ch RCC以负偏态分布为主,两者偏度值有统计学意义(P<0.05),而峰度值无统计学意义(P>0.05)。对pRCC与ChRCC的鉴别诊断效能分析提示,最大值的敏感度最优(91.30%),偏度值的特异度(80.00%)及曲线下面积最优(0.773)。结论全容积ADC直方图对鉴别pRCC与ChRCC具有一定的价值,为临床定性诊断提供了参考依据。 Objective To investigate the value of apparent diffusion coefficient(ADC) histogram in differentiating papillary renal cell carcinoma(pRCC) from chromophobe cell renal cell carcinoma(ChRCC). Methods The data of 23 cases of pRCC and 20 cases of ChRCC were analyzed retrospectively. Patients underwent conventional MRI scan, enhanced scan and diffusion weighted imaging(Diffusionweighted imaging DWI). The parameters of ADC histogram of the two groups were measured, including minimum, average, median, maximum, skewness and kurtosis. The differences of each parameter and their diagnostic efficacy were analyzed. Results The minimum, average and median values of ADC histogram of pRCC were lower than those of ChRCC, while the maximum values were higher than those of ChRCC(P<0.05). Positive skewness distribution was the dominant factor in pRCC, while negative skewness distribution was the dominant factor in ChRCC. The skewness of pRCC and ChRCC had statistical significance(P<0.05), but the kurtosis had no statistical significance(P>0.05). The discriminant diagnosis efficiency analysis of pRCC and ChRCC indicated that the sensitivity of maximum value was the best(91.30%), the specificity of skewness value(80.00%) and the area under curve(0.773) were the best. Conclusion ADC histogram has certain value in differentiating pRCC from ChRCC, and provides reference for clinical qualitative diagnosis.
作者 韩云 张跃 HAN Yun;ZHANG Yue(Department of Radiology,Wuhan No.1 Hospital,Wuhan Hubei 430022,China)
出处 《中国医疗设备》 2019年第12期72-75,共4页 China Medical Devices
关键词 全容积表观扩散系数直方图 乳头状肾癌 嫌色细胞肾癌 apparent diffusion coefficient histogram papillary renal cell carcinoma chromophobe renal cell carcinoma
  • 相关文献

参考文献8

二级参考文献53

  • 1刘丽娜,陈光勇,王鹏,张长淮,黄受方.33例乳头状肾细胞癌的临床病理及免疫组织化学研究[J].中华肿瘤杂志,2005,27(2):102-105. 被引量:12
  • 2Reuter VE. The pathology of renal epithelial neoplasms. SeminOncol, 2006, 33(5): 534-543.
  • 3Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cellcarcinoma: a clinical, radiologic, and pathologic study of 34cases. Cancer, 1976,38(6): 2469-2480.
  • 4Amin MB,Amin MB, Tamboli P, et al. Prognostic impact ofhistologic subtyping of adult renal epithelial neoplasms: anexperience of 405 cases. Am J Surg Pathol, 2002, 26(3): 281-291.
  • 5Pignot G, Elie C, Conquy S, et al. Survival analysis of 130patients with papillary renal cell carcinoma: prognostic utilityof type 1 and type 2 subclassification. Urology, 2007,69(2):230-235.
  • 6Roy C,Sauer B, Lindner V,et al. MR imaging of papillaryrenal neoplasms: potential application for characterization ofsmall renal masses. Eur Radiol, 2007, 17(1): 193-200.
  • 7Akhtar M, Kardar H. Linjawi T, et al. Chromophobe cellcarcinoma of the kidney. Am J Surg Pathol, 1995, 19(11):1245-1256.
  • 8Choueiri TK, Plantade A, Elson P, et al. Efficacy of sunitiniband sorafenib in metastatic papillary and chromophobe renalcell carcinoma. J Clin Oncol, 2008, 26(1): 127-131.
  • 9Schrader AJ, Olbert PJ, Hegele A, et al. Metastatic non-clearcell renal cell carcinoma: current therapeutic options. BJU Int,2008,101(11): 1343-1345.
  • 10Wang H, Cheng L, Zhang X, et al. Renal cell carcinoma:diffusion-weighted MR imaging for subtype differentiation at3.0 T. Radiology, 2010, 257(1): 135-143.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部